GUPTA, V. K.; PANNU, D.; SINGH, M. P.; KUMAR, L. Effect of SGLT-2 inhibitor (remogliflozin) plus DPP4 inhibitor (vildagliptin) on diabetic nephropathy in patients with type 2 diabetes mellitus comparison with combination of metformin and sulphonylureas. International Journal of Advances in Medicine, [S. l.], v. 10, n. 6, p. 446–451, 2023. DOI: 10.18203/2349-3933.ijam20231450. Disponível em: https://www.ijmedicine.com/index.php/ijam/article/view/3839. Acesso em: 16 nov. 2025.